Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,380 | -36,637 | -23,903 | -11,401 | -37,467 |
| Depreciation Amortization | 1,464 | 1,173 | 823 | 439 | 1,933 |
| Accounts receivable | 116 | 116 | 116 | 116 | -116 |
| Accounts payable and accrued liabilities | 1,542 | 997 | 74 | -234 | -2,032 |
| Other Working Capital | -4,738 | -3,856 | -3,552 | -2,704 | -6,713 |
| Other Operating Activity | 1,696 | 1,393 | 1,449 | 945 | 6,196 |
| Operating Cash Flow | $-47,300 | $-36,814 | $-24,993 | $-12,839 | $-38,199 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,019 | -10,350 | -17,321 | -3,192 | -19,666 |
| PPE Investments | -690 | -308 | -45 | -10 | -136 |
| Investing Cash Flow | $9,329 | $-10,658 | $-17,366 | $-3,202 | $-19,802 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,000 | 2,000 | 2,000 | 2,000 | 15,000 |
| Debt Repayment | -579 | -423 | -268 | -87 | -1,834 |
| Common Stock Issued | 35,315 | 35,228 | 35,208 | 190 | 31,990 |
| Financing Cash Flow | $36,736 | $36,805 | $36,940 | $2,103 | $45,156 |
| Beginning Cash Position | 31,310 | 31,310 | 31,310 | 31,310 | 44,155 |
| End Cash Position | 30,075 | 20,643 | 25,891 | 17,372 | 31,310 |
| Net Cash Flow | $-1,235 | $-10,667 | $-5,419 | $-13,938 | $-12,845 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,300 | -36,814 | -24,993 | -12,839 | -38,199 |
| Capital Expenditure | -690 | -308 | -45 | -10 | -136 |
| Free Cash Flow | -47,990 | -37,122 | -25,038 | -12,849 | -38,335 |